Home > Blog > Data analysis excellence the backbone of successful marketing applications

1 min read

Data Analysis Excellence: The Backbone of Successful Marketing Applications

Clinical Trial Regulations Regulatory Consulting Regulatory Submissions

In the complex landscape of marketing application preparation, data analysis stands as a critical cornerstone that can either propel a submission forward or become its greatest challenge. With shifting deadlines, potential delays in data receipt, and the intricate dance of database locks and unblinding, the biostatistical programming portion of submissions presents both challenges and opportunities for strategic management.

👉  Team Structure and Planning

The foundation of successful data analysis begins with team structure. Rather than viewing the submission team as separate entities divided by company lines or departmental boundaries, the most successful approaches treat the team as one cohesive unit driving toward a common goal. This is particularly crucial for biostatistics leads, who must balance their technical expertise with managerial skills.

Key planning elements include:

  • Statistical Analysis Plan development
  • Data conversion strategy
  • SDTM, ADaM, and TLF prioritization
  • Stakeholder alignment meetings
👉  Managing Complexity 

When facing tight submission timelines – an almost universal challenge – the Statistical Analysis Plan (SAP) emerges as a primary timeline driver. It dictates the pooling approach and allows the planning team to work backwards to develop the optimal data conversion and analysis plan. One often-overlooked strategy involves conducting pre-SAP meetings – strategic discussions that bring together not just biostatistics teams, but also medical writing, regulatory, medical, and other key stakeholders.

👉  Quality Assurance and Integration

For integrated analyses, which often combine various Clinical Study Report (CSR) analyses, quality and consistency become paramount. Statistical teams must familiarize themselves with individual CSRs to understand which analyses have been conducted or are planned, ensuring alignment with the integrated analysis.

Critical quality measures include:

  • Comprehensive statistical review checks
  • Automated quality monitoring systems
  • Consistent cross-team standards
  • Thorough verification processes

Success in data analysis requires a delicate balance of technical expertise, strategic thinking, and effective team management. By implementing these key strategies while maintaining unwavering commitment to quality, teams can navigate the complex data requirements of marketing applications more effectively and efficiently.

Imagine that your teams have been working at warp speed to meet your NDA timeline and you finally complete the submission to the FDA. You should be celebrating! But wait, the FDA responds with a Refusal to File letter. It happens!

Learn how Veristat performed an independent statistical review, explained the findings to the FDA, and helped the global pharmaceutical company fix the data to re-submit the NDA to the FDA.

 

6 min read

Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support

May 7, 2025  Veristat Events

With 90 percent of clinical trials failing to reach completion, sponsors need innovative approaches that blend...

2 min read

ASCO Annual Meeting

Apr 23, 2025  Veristat Events

Meet Veristat at the 2025 ASCO Annual Meeting 

Advancing Oncology Therapies for Patients in Need 

Veristat is proud to...